BIOTEST AG VZ O.N./ DE0005227235 /
| 2024-04-17 5:36:24 PM | Chg. - | Volume | Bid10:33:47 AM | Ask10:33:47 AM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 28.900EUR | - | 1 Turnover: 28.500 |
28.300Bid Size: 174 | 29.000Ask Size: 374 | 1.63 bill.EUR | 0.10% | - |
Assets
| 2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 254.9000 | 282.3000 | 317.2000 | 414.9000 | 477.1000 | ||||||
| Intangible Assets | 48.1000 | 50.2000 | 44.7000 | 25.3000 | 16.6000 | ||||||
| Long-Term Investments | .2000 | 5.2000 | .8000 | 8 | 13 | ||||||
| Fixed Assets | 324 | 353.3000 | 375.9000 | 465.6000 | 528.8000 | ||||||
| Inventories | 227 | 246 | 218.7000 | 170.8000 | 146.9000 | ||||||
| Accounts Receivable | 118.5000 | 181.6000 | 173.9000 | 163.8000 | 133.8000 | ||||||
| Cash and Cash Equivalents | 204.4000 | 179.4000 | 53.8000 | 72.9000 | 22.3000 | ||||||
| Current Assets | 562.5000 | 679.3000 | 586.8000 | 467.2000 | 449.7000 | ||||||
| Total Assets | 886.5000 | 1,032.6000 | 962.7000 | 932.8000 | 978.5000 | ||||||
Liabilities
| 2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 51.4000 | 55.5000 | 53.1000 | 62.8000 | 65 | ||||||
| Long-term debt | 226.2000 | 325.8000 | 335.5000 | 330 | 286.8000 | ||||||
| Liabilities to Banks | 231.5000 | 331.9000 | 344.6000 | 346.2000 | 406.4000 | ||||||
| Provisions | 47.7000 | 49.8000 | 46.1000 | 49.5000 | 30.6000 | ||||||
| Liabilities | 425.8000 | 552.4000 | 550.4000 | 572.1000 | 630.7000 | ||||||
| Share Capital | 33.8000 | 33.8000 | 39.6000 | 39.6000 | 39.6000 | ||||||
| Total Equity | 460.6000 | 480.1000 | 412.2000 | 360.5000 | 347.6000 | ||||||
| Minority Interests | .1000 | .1000 | .1000 | .2000 | .2000 | ||||||
| Total liabilities equity | 886.5000 | 1,032.6000 | 962.7000 | 932.8000 | 978.5000 | ||||||
Income Statement
| 2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 500.8000 | 582 | 589.6000 | 553.1000 | 378.1000 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | 53.8000 | 53.4000 | -71.8000 | 63.9000 | -9.3000 | ||||||
| Interest Income | -7 | -6.5000 | -4.5000 | -12.6000 | -16.8000 | ||||||
| Income Before Taxes | 47.8000 | 46.9000 | -74.3000 | 52.7000 | -26 | ||||||
| Income Taxes | 15.8000 | 27.7000 | 8.2000 | 18.2000 | -9.6000 | ||||||
| Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Net Income | 32 | 19.2000 | -82.5000 | -45.7000 | -3.5000 | ||||||
Per Share
Cash Flow
| 2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | -7.2000 | -11.4000 | 38.1000 | 65.9000 | 34.3000 | ||||||
| Cash Flow from Investing Activities | -32.3000 | -102.4000 | -160.1000 | -34 | -148 | ||||||
| Cash Flow from Financing | 186.9000 | 87.4000 | -4.6000 | -1.7000 | 55.2000 | ||||||
| Decrease / Increase in Cash | 147.4000 | -26.4000 | -126.6000 | 30.2000 | -58.5000 | ||||||
| Employees | 2,160 | 2,332 | 2,443 | 2,732 | 2,683 | ||||||
